Conference Coverage

April 3, 2017

FDA approvals for specialty drugs to increase in 2017

Numerous specialty medications, generics, and biosimilars, are expected to be approved this year.

Find out what's in the pipeline

State medical marijuana laws continue to expand

Medical marijuana's therapeutic evidence base remains nascent and controversial but the regulatory landscape is evolving rapidly.

Predictive analytics reduces chemotherapy-associated hospitalizations

Data analytics can improve value-based cancer care.

Find out how

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

>>>>>>>